BioSpace News Archive

BioRestorative Therapies, Inc., a life sciences company focused on adult stem cell-based therapies, announced the pricing of the underwritten public offering of 2,300,000 units, each consisting of one share of its common stock and a warrant to purchase one share of its common stock at a per unit price of $10.00.

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B, and age-related diseases, announced that abstracts on six studies of the company’s three drug candidates have been selected for poster presentations and one oral presentation at the 63rd American Society of Hematology Annual Meeting.

Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biotechnology company, today announced financial results for its third quarter ended September 30, 2021.

Novavax, Inc. today announced its financial results and operational highlights for the third quarter ended September 30, 2021.

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2021, which include the consolidated financial results of GRAIL.

Cryoport, Inc. today announced financial results for the three- and nine-month periods ended September 30, 2021.

Verastem Oncology today reported financial results for the three months ended September 30, 2021 and highlighted recent progress.

Aerie Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2021 and provided a general business update.

Quanterix Corporation today announced financial results for the three months ending September 30, 2021.

Acceleron Pharma Inc. today reported financial results for the third quarter ended September 30, 2021.